Show source-provided references
1. Cancer treatment survivorship statistics 2025: An urgent call to optimize health after cancer
3. Rising above: Exploring the therapeutic potential of natural product-based compounds in human cancer treatment
10.53388/TMR20240618001 ↗4. Ovarian tumor microenvironment contributes to tumor progression and chemoresistance
5. The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers
10.20517/cdr.2023.29 ↗6. Wang, Z., Sun, X., Sun, M., Wang, C., and Yang, L. (2025). Game changers: Blockbuster small-molecule drugs approved by the FDA in 2024. Pharmaceuticals, 18.
10.3390/ph18050729 ↗7. Therapeutic potential of oncolytic viruses in the era of precision oncology
9. Integration of artificial intelligence in clinical laboratory medicine: Advancements and challenges
10.1002/INMD.20230056 ↗12. Unlocking the potential of immunotherapy in platinum-resistant ovarian cancer: Rationale, challenges, and novel strategies
13. Oncogenic viral antigens for engineered T cell immunotherapy: Challenges and opportunities
10.1002/med4.37 ↗14. HER3-targeted therapy: The mechanism of drug resistance and the development of anticancer drugs
15. Yang, L., and Wang, Z. (2021). Natural products, alone or in combination with FDA-approved drugs, to treat COVID-19 and lung cancer. Biomedicines, 9.
10.3390/biomedicines9060689 ↗16. Thao, L.T.P., Nguyen, T., and Singh, J. (2025). Low-dose aspirin for individualized cancer prevention in older adults: A secondary analysis of the ASPREE randomized clinical trial. JAMA Oncol.
10.1001/jamaoncol.2025.3593 ↗19. Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment
20. Kalayil, N., Budar, A.A., and Dave, R.K. (2024). Nanofibers for drug delivery: Design and fabrication strategies. BIO Integr., 5.
10.15212/bioi-2024-0023 ↗21. Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment
23. Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance
10.20517/cdr.2023.78 ↗24. New mechanisms of multidrug resistance: An introduction to the cancer drug resistance special collection
10.20517/cdr.2023.86 ↗26. Butler, M.S., Capon, R.J., Blaskovich, M.A., and Henderson, I.R. (2025). Natural product-derived compounds in clinical trials and drug approvals. Nat. Prod. Rep.
10.1039/D5NP00031A ↗27. Wang, Z., and Yang, L. (2020). Turning the tide: Natural products and natural-product-inspired chemicals as potential counters to SARS-CoV-2 infection. Front. Pharmacol., 11.
10.3389/fphar.2020.01013 ↗29. Wang, Z., and Yang, L. (2023). The therapeutic potential of natural dietary flavonoids against SARS-CoV-2 infection. Nutrients, 15.
10.3390/nu15153443 ↗30. Therapeutic effects of Chinese herbal medicines for treatment of urolithiasis: A review
33. Highly oxygenated dihydrostilbenoids and flavones from the aerial part of Glycyrrhiza uralensis and their antimicrobial activities
10.1097/st9.0000000000000048 ↗34. Wang, Z. (2019). Advances in the asymmetric total synthesis of natural products using chiral secondary amine catalyzed reactions of α,β-unsaturated aldehydes. Molecules, 24.
10.3390/molecules24183412 ↗36. Ragozzino, C., Casella, V., Coppola, A., Scarpato, S., Buonocore, C., Consiglio, A., Palma Esposito, F., Galasso, C., Tedesco, P., and Della Sala, G. (2025). Last decade insights in exploiting marine microorganisms as sources of new bioactive natural products. Mar. Drugs, 23.
10.3390/md23030116 ↗37. Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice
38. Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents
10.53388/TMR20230626001 ↗39. Integrating tradition and innovation: Health industry opportunities for ginseng with foods and medicines
41. Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms
42. Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill
44. Magnolol and 5fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways
45. Jahangiri, R. (2025). Natural products and derivatives hold promise to improve treatment of unresponsive tumours. Nat. Prod. Res., 1–20.
10.1080/14786419.2025.2505603 ↗46. Wu, K., Kwon, S.H., Zhou, X., Fuller, C., Wang, X., Vadgama, J., and Wu, Y. (2024). Overcoming challenges in small-molecule drug bioavailability: A review of key factors approaches. Int. J. Mol. Sci., 25.
10.3390/ijms252313121 ↗48. Theanine combined with cisplatin inhibits the proliferation and metastasis of TNBC cells through Akt signaling pathway
10.53388/TMR20221025001 ↗49. Wu, J., Li, Y., He, Q., and Yang, X. (2023). Exploration of the use of natural compounds in combination with chemotherapy drugs for tumor treatment. Molecules, 28.
10.3390/molecules28031022 ↗50. Combination of photothermal, prodrug and tumor cell camouflage technologies for triple-negative breast cancer treatment
10.1016/j.mtadv.2021.100199 ↗51. Bargakshatriya, R., and Pramanik, S.K. (2023). Stimuli-responsive prodrug chemistries for cancer therapy. ChemBioChem, 24.
10.1002/cbic.202300155 ↗52. Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
10.20517/cdr.2023.16 ↗54. Drug delivery of natural products through nanocarriers for effective breast cancer therapy: A comprehensive review of literature
10.2147/IJN.S328135 ↗55. Recent advanced lipid-based nanomedicines for overcoming cancer resistance
56. Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression
57. Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
10.1016/j.phrs.2024.107150 ↗58. Recent advances in carrier-free natural small molecule self-assembly for drug delivery
10.1039/D4BM01153H ↗59. Li, G., Cai, C., Zhang, N., Wang, Z., Zhang, M., Liu, Q., Chen, S., Shang, Y., Zhao, C., and Ren, S. (2025). Carrier-free procyanidin-ferric nanonetworks loading gefitinib to inhibit TMEM16A-EGFR mutual activation loop for photothermally enhanced breast cancer targeted therapy. Mater. Today Bio, 35.
10.1016/j.mtbio.2025.102426 ↗62. An, J., Zhang, Z., Zhang, J., Zhang, L., and Liang, G. (2024). Research progress in tumor therapy of carrier-free nanodrug. Biomed. Pharmacother., 178.
10.1016/j.biopha.2024.117258 ↗66. Wang, Z., Song, X.Q., Xu, W., Lei, S., Zhang, H., and Yang, L. (2023). Stand up to stand out: Natural dietary polyphenols curcumin, resveratrol, and gossypol as potential therapeutic candidates against severe acute respiratory syndrome coronavirus 2 infection. Nutrients, 15.
10.3390/nu15183885 ↗68. Ginsenoside Rb1 in cardiovascular and cerebrovascular diseases: A review of therapeutic potentials and molecular mechanisms
70. Santonocito, D., Campisi, A., Pellitteri, R., Sposito, G., Basilicata, M.G., Aquino, G., and Puglia, C. (2023). Lipid nanoparticles loading steroidal alkaloids of tomatoes affect neuroblastoma cell viability in an in vitro model. Pharmaceutics, 15.
10.3390/pharmaceutics15112573 ↗72. Parodi, A., Buzaeva, P., Nigovora, D., Baldin, A., Kostyushev, D., Chulanov, V., and Zamyatnin, A.A. (2021). Nanomedicine for increasing the oral bioavailability of cancer treatments. J. Nanobiotechnol., 19.
10.1186/s12951-021-01100-2 ↗73. Enhancing drugs bioavailability using nanomedicine approach: Predicting solubility of Tolmetin in supercritical solvent via advanced computational techniques
10.1016/j.molliq.2022.120103 ↗76. A computer-aided heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer enhance efficiency
10.1016/j.jcis.2024.08.100 ↗77. Wang, X., Sun, K., Dong, J., Ge, Y., Liu, H., Jin, X., and Yu, X.A. (2025). Carrier-free nanoparticles based on natural products trigger dual "synergy and attenuation" for enhanced phototherapy of liver cancer. Mater. Today Bio, 35.
10.1016/j.mtbio.2025.102278 ↗78. Lu, Z., Wang, T., Xu, X., Hu, Q., Wang, L., and Jin, Y. (2025). Carrier-free nano-integrated strategy of phototherapy and chemotherapy for synergetic AKT targeted therapy to inhibit cancer metastasis and recurrence. J. Nanobiotechnol., 23.
10.1186/s12951-025-03539-z ↗79. Self-assembled dual-targeting nanoplatform for synergistic photodynamic and PROTAC-mediated metabolic starvation in triple-negative breast cancer
10.1016/j.cej.2025.165815 ↗80. Glycosylated AIE-active red light-triggered photocage with precisely tumor targeting capability for synergistic type I photodynamic therapy and CPT chemotherapy
10.1002/anie.202413350 ↗81. Preclinical and first-in-human study of a compact radionuclide labeled self-assembly nanomedicine for chemo-radio-theranostics of cancer
10.1021/acsnano.4c18489 ↗84. Gilad, Y., Gellerman, G., Lonard, D.M., and O’malley, B.W. (2021). Drug combination in cancer treatment—From cocktails to conjugated combinations. Cancers, 13.
10.3390/cancers13040669 ↗85. cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer
10.1039/D2NH00590E ↗86. Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies benefits challenges
10.1002/jmv.27517 ↗88. Iova, V., Iova, G.M., Tiron, A.T., Scrobota, I., Vlad, S., and Tudosie, M.S. (2025). Latest achievements in the development of nanoparticle-based drug delivery systems of Pt drugs and prodrugs in cancer therapy. Pharmaceutics, 17.
10.3390/pharmaceutics17101267 ↗89. A computer-aided, carrier-free drug delivery system with enhanced cytotoxicity and biocompatibility: A universal model for multifunctional lung cancer therapy
10.1016/j.colsurfb.2025.114557 ↗90. An activatable carrier-free triple-combination nanomedicine for ALK/EGFR-mutant non-small cell lung cancer highly permeable targeted chemotherapy
10.1039/D2NJ03231G ↗91. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: From molecular design to application
10.1039/D0CS00173B ↗93. Screening of photosensitizers-ATP binding cassette (ABC) transporter interactions in vitro
94. Recent advances in photosensitizers as multifunctional theranostic agents for imaging-guided photodynamic therapy of cancer
10.7150/thno.62479 ↗95. Correia, J.H., Rodrigues, J.A., Pimenta, S., Dong, T., and Yang, Z. (2021). Photodynamic therapy review: Principles, photosensitizers, applications, and future directions. Pharmaceutics, 13.
10.3390/pharmaceutics13091332 ↗97. Essential role of medicine and food homology in health and wellness
99. Advances and challenges of medicine and food homology earthworms: Active ingredients, efficacy and quality control
10.1016/j.tifs.2025.105065 ↗100. ‘Food and medicine continuum’ in the East and West: Old tradition and current regulation